Company Profile

Shandong Shining Medical Science and Technology Co., Ltd.(Shining Pharm) was founded in 2013,headquartered in Yinfeng International Biological City in Jinan. Shining Pharm focuses on manufacturing critical materials for investigational new drug (IND), generic drug, and nucleic acid drug as well as its delivery systems, with 2 subsidiaries:Shandong Shining Pharm Co.,Ltd. and Shining Laboratories (Shanghai) Co., Ltd.

Shandong Shining Pharm Co.,Ltd, which is located at Ningyang Chemical Industrial Park of Shandong Province (the first batch of certified industrial park in Shandong Province).The factory is managed according to GMP system with a complete quality control system. With a total reaction capacity of 210,000 liters, which can realize bromination, high pressure, high temperature (250℃), low temperature (-78℃), format reaction, Suzuki reaction, etc., and can meet the commercial production demand from kilogram to ton.

Shining Laboratories (Shanghai) Co., Ltd. is located in Pudong New Area of Shanghai. It has a research team is mainly composed of doctors and masters, with synthesis laboratory, pilot-scale laboratory, analysis center, etc. and the laboratories are fully equipped. It is responsible for the synthesis process development and quality research of generic drug APIs and intermediates, as well as the transformation and connection between laboratory process and pilot-scale process, and focusing on CDMO business of new drug intermediates.

Shining Pharm has been committed to the development and production of pharmaceutical products, vigorously introduce technology and management personnel, constantly improve the quality system, and the current advantages are as follows

1. CDMO business, which mainly provides high-quality products and services for international and domestic innovative drug enterprises and biotech companies, has completed more than 400 intermediates of 1.1 class of new drugs at home and abroad.
2. Generic drug business, mainly providing high-end generic drug intermediates for customers. Currently, 27 generic drug projects have been completed. Customers throughout the domestic major pharmaceutical enterprises, CRO companies and other R&D institutions; In the international market, we have close cooperation with enterprises from India, Japan, South Korea, Russia, Egypt, Pakistan, Bangladesh, Europe and the United States, and established a good long-term relationship of cooperation.
3. Nucleic acid drug monomer and delivery system has served many well-known domestic and international pharmaceutical companies.

"123Moral commitment, professional service, benefit the society, create a better life!" Is our business philosophy. We sincerely welcome domestic and oversea customers to negotiate, start win-win cooperation, and create a better future!